James B. Breitmeyer, EVP, CMO at CADENCE PHARMACEUTICALS INC (CADX), sold 7,000 shares at $8.50 ($60K) on 2010-09-29, disclosed to the SEC on 2010-09-29.
Scheduled sale ($60k) by EVP, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 2,363 | $20K | 33.8% |
| 2 | $8.50 | 4,637 | $39K | 66.2% |
| Total | $8.50 avg | 7,000 | $60K | 100% |
| Filing → |
| ZGNX | SELL | 2019-12-18 | $250K | — | Filing → |
| ZGNX | SELL | 2019-11-27 | $250K | — | Filing → |
| CADX | SELL | 2011-11-04 | $71K | — | Filing → |